Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bionano Genomics Inc (NQ: BNGO )

5.660 -0.450 (-7.36%)
Official Closing Price Updated: 7:59 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Bionano Genomics Inc

< Previous 1 2 3 4 5 Next >
Thinking about buying stock in Sundial Growers, Zomedica, Naked Brand, Meten Edtechx Education, or BioNano Genomics?
InvestorsObserver issues critical PriceWatch Alerts for SNDL, ZOM, NAKD, METX, and BNGO. 
From PR Newswire
Bionano Genomics Announces Pre-Clinical Evaluation of Optical Genome Mapping by the Foundation for Embryonic Competence
From GlobeNewswire News Releases
Bionano Genomics Announces Record Number of Presentations on Optical Genome Mapping and Structural Variation at the 2021 Annual Clinical Genetics Meeting of the ACMG
Sixteen talks and posters, fourteen of which are from US institutions, to be presented across all four of Bionano’s main target growth markets: prenatal, postnatal/constitutional genetics, blood... 
From GlobeNewswire News Releases
Bionano Genomics Announces Presentations on Optical Genome Mapping at the American Association for Cancer Research (AACR) Annual Meeting 2021
From GlobeNewswire News Releases
Bionano Genomics Announces Continued Global Expansion in Adoption of its Saphyr System with Addition of Indalo Bio in South Africa, Bringing Advanced Genetic Analysis to Africa
From GlobeNewswire News Releases
Publication Outlines Potential for Optical Genome Mapping with Bionano’s Saphyr System to be the Foundation of a New Workflow in Prenatal Genetic Testing
From GlobeNewswire News Releases
Bionano Genomics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates
From GlobeNewswire News Releases
Investing in Rapidly Growing Autism Therapy Market (NASDAQ: BNGO) (OTC US: ISWH) (NASDAQ: ZYNE)
Tags CBD Marketing OTC PR WIRE
From OTC
Bionano Genomics to Present at Several Upcoming Investor Conferences
From GlobeNewswire News Releases
Bionano Genomics Presented at H.C. Wainwright Global Life Sciences Conference
From GlobeNewswire News Releases
Thinking about buying stock in OpGen, GameStop, Johnson & Johnson, BioNano Genomics, or SINTX Technologies?
InvestorsObserver issues critical PriceWatch Alerts for OPGN, GME, JNJ, BNGO, and SINT. 
From PR Newswire
Bionano Genomics to Report Fourth Quarter and Year End 2020 Financial Results and Host a Conference Call and Webcast on March 23rd, 2021
From GlobeNewswire News Releases
Bionano Customer Praxis Genomics Receives DEX Z-Codes from Palmetto for their Whole Genome Analysis LDT on Saphyr
From GlobeNewswire News Releases
Bionano Genomics to Present at the Cowen 41st Annual Health Care Conference
From GlobeNewswire News Releases
Bionano to be Featured at AGBT 2021 with Presentations of Scientific Discoveries made with Saphyr in Psychiatric Disorders and Cancer
From GlobeNewswire News Releases
Bionano’s Saphyr Data Prove Essential in Creating the Most Comprehensive, Ethnically Diverse Collection of Genome Variation Ever Completed
Article published in Science reveals that optical genome mapping uniquely makes thousands of large structural variant calls 
From GlobeNewswire News Releases
Thinking about buying stock in Nokia, BioNano Genomics, TJX Companies, Bank of America, or Advanced Micro Devices?
InvestorsObserver issues critical PriceWatch Alerts for NOK, BNGO, TJX, BAC, and AMD. 
From PR Newswire
Bionano Publishes Method for Identifying Genes Likely to Cause Neurological Diseases Based on a Model Developed by Lineagen to Improve Interpretation of Variants of Unknown Significance
Proprietary scoring algorithm may help identify novel genes for nervous system disorders; applications include patient testing and eventually discovery research with Saphyr 
From GlobeNewswire News Releases
Bionano Genomics to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From GlobeNewswire News Releases
Method for Solid Tumor Analysis with Saphyr Published by Penn State Institute for Personalized Medicine, Opening Largest Oncology Market to Optical Genome Mapping
Publication demonstrates that Saphyr can be powerful and easy to use for solid tumor analysis in cancer research and clinical testing 
From GlobeNewswire News Releases
Largest Hospital Diagnostic Lab in Canada Pilots Bionano’s Saphyr; Seeking to Convert 30-Year-Old Workflow Based on Multiple Technologies Into a Single, High-Resolution Assay to Transform Cancer Diagn
From GlobeNewswire News Releases
Presentation Recordings from Bionano’s Next-Generation Cytogenomics Symposium, its Most Attended Event to Date, Now Available Online
From GlobeNewswire News Releases
Thinking about buying stock in Durect Corp, T2 Biosystems, Gevo Inc, BioNano Genomics, or Advanced Micro Devices?
InvestorsObserver issues critical PriceWatch Alerts for DRRX, TTOO, GEVO, BNGO, and AMD. 
From PR Newswire
Saphyr Study Is First to Analyze Cancer Regulation at Level of Single DNA Molecules, Opens Promising New Avenue of Cancer Research
Publication on novel Saphyr based method to analyze DNA methylation in cancer genomes enables new field of cancer research and drug target discovery 
From GlobeNewswire News Releases
Dr. Gordana Raca from Children’s Hospital Los Angeles Presents Findings That Show Saphyr Detects Druggable Gene Fusions in Pediatric Acute Leukemias that NGS and Cytogenetics Missed
From GlobeNewswire News Releases
Bionano Chief Medical Officer Presents Vision for Optical Genome Mapping as a First Line Clinical Tool for Cancer and Genetic Disease Testing at Festival of Genomics & Biodata
From GlobeNewswire News Releases
Bionano Significantly Reduces Analysis Cost and Time to Actionable Results with Update to its Cloud Compute
Addition of Microsoft Azure as a High-Performance Computing provider reduces compute cost for genetic disease analysis by more than 50%, compute time by 30% 
From GlobeNewswire News Releases
Bionano Genomics Announces Closing of $230 Million Underwritten Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From GlobeNewswire News Releases
Bionano Genomics Announces Pricing of $200 Million Underwritten Public Offering of Common Stock
From GlobeNewswire News Releases
Bionano Genomics Announces Proposed Underwritten Public Offering of Common Stock
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.